A 72% Hit Rate at 30 Days, But the Tape Fights Back

ISB Research · Interesting · sent to Ultimate members August 13, 2026

CFO Oran Baris put $283,530 into Amrize at $47.26, and he's bought this name before. The 30-day history here is genuinely good, right about 7 out of 10 buys turning a profit and beating the market by a solid margin. The problem is the trend reads sell across every timeframe, price sits below both the 8-day and 20-day, and the 90-day track record on this ticker basically flatlines. So the short-term odds favor him, but you're buying into a downtrend with a CFO who tends to be early. Let it firm up near the $46.03 support before you follow.

Ultimate members received this analysis in real time.